The regulation establishing the EU digital COVID certificate will be prolonged by one year, until 30 June 2023. The extension of the regulation will ensure that EU travellers as well as those from third countries connected to the system can continue to use their EU digital COVID certificate for travel within the Union in member states where these travel certificates are required.
The Directive establishes a framework for the adequacy of statutory minimum wages, promoting collective bargaining on wage setting, and enhancing the effective access of workers to minimum wage protection in the EU. The main elements of the Directive are: A framework for setting and updating statutory minimum wages, Promoting and facilitating collective bargaining on wages, and Improved monitoring and enforcement of minimum wage protection.
New rules on in vitro diagnostic medical devices (IVDR) such as HIV tests, pregnancy tests or COVID-19 tests, are now applicable. The rules will better protect public health and patient safety in respect to these devices, bringing EU law in line with technological advances and progress in medical science. By aligning market access requirements in the different EU Member States, it also safeguards fair market access for manufacturers.
On May 18th, Member States, workers and employers in the EU Advisory Committee on Safety and Health at Work (ACSH) reached an agreement on the need to recognise COVID-19 as an occupational disease in health and social care and in domiciliary assistance and, in a pandemic context, in sectors where there is an outbreak in activities with proven risk of infection, and supported an update of the EU list of occupational diseases.
The European strategy for data proposed the establishment of domain-specific common European data spaces. The European Health Data Space (‘EHDS’) is the first proposal of such domain-specific common European data spaces. It will address health-specific challenges to electronic health data access and sharing, is one of the priorities of the European Commission in the area of health and will be an integral part of building a European Health Union.
The EU helps to improve public health though funding and legislation on a wide range of topics, such as food, diseases, clean air and more. National goverments are primarily responsible for organising and delivering healthcare and social security. The EU's role is to complement and support member states in improving the health of Europeans, reducing health inequalities and moving towards a more social Europe. EU public health policy has helped countries pool resources and tackle common challenges.
Today, the Commission is proposing to update the EU consumer rules to empower consumers for the green transition. The updated rules will ensure that consumers can take informed and environment-friendly choices when buying their products. Consumers will have a right to know how long a product is designed to last for and how, if at all, it can be repaired. In addition, the rules will strengthen consumer protection against untrustworthy or false environmental claims, banning ‘greenwashing'.
The Commission welcomes the swift political agreement reached between the European Parliament and EU Member States on the Digital Markets Act (DMA). The regulation, agreed in slightly more than a year after it was proposed, is among the first initiatives of its kind to comprehensively regulate the gatekeeper power of the largest digital companies.
It brings together regional development agencies. It allows us to access events, it helps us with the search for European partners to participate in interregional European projects. And we use its infrastructures and rooms for our own events or those of Navarran actors. Navarre´s Participation: SODENA
The European Commission has adopted its guidelines on the general regime of conditionality, which aims to protect the EU budget against breaches of the principles of the rule of law. The guidelines explain in detail how the Commission will apply the regulation, including how the rights of the final recipients and beneficiaries of EU funding will be protected.
COMMISSION IMPLEMENTING REGULATION (EU) 2022/20 of 7 January 2022 laying down rules for the application of Regulation (EU) No 536/2014 of the European Parliament and of the Council as regards setting up the rules and procedures for the cooperation of the Member States in safety assessment of clinical trials.
In the context of the COVID-19 pandemic Member States, health institutions and economic operators redeployed financial and other resources to address the unprecedented challenges of the crisis. By doing so, they delayed the implementation of the In Vitro Diagnostic Medical Devices Regulation of 2017, which introduced certain requirements for medical devices and a stronger role for so-called conformity assessment bodies.